SOUTH KOREA · OPENDART
GC Genome Corporation
지씨지놈 · 340450 · KOSDAQ · Healthcare · Biotechnology
Score
Not ranked: no net buying on the exchange by an individual insider in the last 180 days.
Insiders' buying price vs the latest close
Insiders paid 6,725.00 KRW a share on average (1 purchase line, 1 buyer, 2026-01-21 – 2026-01-21). The close on 2026-10-16 was 37.2% above that price.
Prices paid are weighted by shares and taken from the filings; dividends are not counted. Not scored.
Insider trades on the exchange
Purchases and sales on the exchange in the last 12 months. The filing gives the settlement date; the trade date is two trading days earlier.
| Trade date | Insider | Role | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-01-21 | Cho Eun-hae | Executive | Bought on the exchange | 10,000 | ₩6,725 | ₩67.2M | DART ↗ |
Other changes in holdings · 13
Option exercises, grants, new shares, inheritance, gifts, off-exchange trades and trades by companies and funds. Not counted in the score.
| Date | Insider | Role | Reason | Shares | Filing |
|---|---|---|---|---|---|
| 2025-12-17 | Genovation I Private Equity Fund | 10% shareholder | Disposal in exchange(-) | 3,650 | DART ↗ |
| 2025-12-16 | Genovation I Private Equity Fund | 10% shareholder | Disposal in exchange(-) | 95,000 | DART ↗ |
| 2025-12-15 | Genovation I Private Equity Fund | 10% shareholder | Disposal in exchange(-) | 531,000 | DART ↗ |
| 2025-12-12 | Genovation I Private Equity Fund | 10% shareholder | Disposal in exchange(-) | 100,000 | DART ↗ |
| 2025-12-11 | Genovation I Private Equity Fund | 10% shareholder | Disposal in exchange(-) | 259,444 | DART ↗ |
| 2025-06-18 | Genovation I Private Equity Fund | 10% shareholder | Disposal in exchange(-) | 45,000 | DART ↗ |
| 2025-06-17 | Genovation I Private Equity Fund | 10% shareholder | Disposal in exchange(-) | 55,000 | DART ↗ |
| 2025-06-16 | Genovation I Private Equity Fund | 10% shareholder | Disposal in exchange(-) | 100,000 | DART ↗ |
| 2025-06-13 | Genovation I Private Equity Fund | 10% shareholder | Disposal in exchange(-) | 511,111 | DART ↗ |
| 2025-06-11 | Ki Chang-seok | CEO | New listing(+) | 169,285 | DART ↗ |
| 2025-06-11 | Cho Eun-hae | Executive | New listing(+) | 138,250 | DART ↗ |
| 2025-06-11 | GC Biopharma Corp. | 10% shareholder | New listing(+) | 4,636,500 | DART ↗ |
| 2025-06-11 | Genovation I Private Equity Fund | 10% shareholder | New listing(+) | 3,555,555 | DART ↗ |